Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Lewis

Showing results (331-340 of 359) with videos related to

Pageof 36
Sort By:
Journal of Hematology & Oncology|November 12, 2022
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignanciesKim Kramer, Neeta Pandit-Taskar, Brian H Kushner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2019
First-in-Humans Imaging with <sup>89</sup>Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion TargetingNeeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2020
First-in-Human Trial of Epichaperome-Targeted PET in Patients with CancerMark P S Dunphy, Christina Pressl, Nagavarakishore Pillarsetty, et al.
Pediatric Blood & Cancer|September 24, 2017
A phase II study of radioimmunotherapy with intraventricular <sup>131</sup> I-3F8 for medulloblastomaKim Kramer, Neeta Pandit-Taskar, John L Humm, et al.
Science Signaling|March 27, 2014
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancerJessica J Tao, Pau Castel, Nina Radosevic-Robin, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2014
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Volkan Beylergil, et al.
Science Translational Medicine|April 17, 2015
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancerAna Bosch, Zhiqiang Li, Anna Bergamaschi, et al.
JCO Precision Oncology|November 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine NeoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Science Translational Medicine|December 2, 2016
Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axisDaniel L J Thorek, Philip A Watson, Sang-Gyu Lee, et al.
Pageof 36

Showing results (331-340 of 359) with videos related to

Sort By:
Pageof 36
Journal of Hematology & Oncology|November 12, 2022
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignanciesKim Kramer, Neeta Pandit-Taskar, Brian H Kushner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2019
First-in-Humans Imaging with <sup>89</sup>Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion TargetingNeeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2020
First-in-Human Trial of Epichaperome-Targeted PET in Patients with CancerMark P S Dunphy, Christina Pressl, Nagavarakishore Pillarsetty, et al.
Pediatric Blood & Cancer|September 24, 2017
A phase II study of radioimmunotherapy with intraventricular <sup>131</sup> I-3F8 for medulloblastomaKim Kramer, Neeta Pandit-Taskar, John L Humm, et al.
Science Signaling|March 27, 2014
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancerJessica J Tao, Pau Castel, Nina Radosevic-Robin, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2014
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Volkan Beylergil, et al.
Science Translational Medicine|April 17, 2015
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancerAna Bosch, Zhiqiang Li, Anna Bergamaschi, et al.
JCO Precision Oncology|November 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine NeoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Science Translational Medicine|December 2, 2016
Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axisDaniel L J Thorek, Philip A Watson, Sang-Gyu Lee, et al.
Pageof 36